These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16414995)

  • 21. Iron inactivates the RNA polymerase NS5B and suppresses subgenomic replication of hepatitis C Virus.
    Fillebeen C; Rivas-Estilla AM; Bisaillon M; Ponka P; Muckenthaler M; Hentze MW; Koromilas AE; Pantopoulos K
    J Biol Chem; 2005 Mar; 280(10):9049-57. PubMed ID: 15637067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance analysis and characterization of NITD008 as an adenosine analog inhibitor against hepatitis C virus.
    Qing J; Luo R; Wang Y; Nong J; Wu M; Shao Y; Tang R; Yu X; Yin Z; Sun Y
    Antiviral Res; 2016 Feb; 126():43-54. PubMed ID: 26724382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of hepatitis C virus replication by single-stranded RNA structural mimics.
    Smolic R; Smolic M; Andorfer JH; Wu CH; Smith RM; Wu GY
    World J Gastroenterol; 2010 May; 16(17):2100-8. PubMed ID: 20440850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs.
    Carroll SS; Tomassini JE; Bosserman M; Getty K; Stahlhut MW; Eldrup AB; Bhat B; Hall D; Simcoe AL; LaFemina R; Rutkowski CA; Wolanski B; Yang Z; Migliaccio G; De Francesco R; Kuo LC; MacCoss M; Olsen DB
    J Biol Chem; 2003 Apr; 278(14):11979-84. PubMed ID: 12554735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.
    Horscroft N; Bellows D; Ansari I; Lai VC; Dempsey S; Liang D; Donis R; Zhong W; Hong Z
    J Virol; 2005 Mar; 79(5):2788-96. PubMed ID: 15708997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zinc is a negative regulator of hepatitis C virus RNA replication.
    Yuasa K; Naganuma A; Sato K; Ikeda M; Kato N; Takagi H; Mori M
    Liver Int; 2006 Nov; 26(9):1111-8. PubMed ID: 17032412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracellular accumulation of hepatitis C virus proteins in a human hepatoma cell line.
    Brazzoli M; Crotta S; Bianchi A; Bagnoli F; Monaghan P; Wileman T; Abrignani S; Merola M
    J Hepatol; 2007 Jan; 46(1):53-9. PubMed ID: 17107733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways.
    Trujillo-Murillo K; Rincón-Sánchez AR; Martínez-Rodríguez H; Bosques-Padilla F; Ramos-Jiménez J; Barrera-Saldaña HA; Rojkind M; Rivas-Estilla AM
    Hepatology; 2008 May; 47(5):1462-72. PubMed ID: 18393288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The FUSE binding protein is a cellular factor required for efficient replication of hepatitis C virus.
    Zhang Z; Harris D; Pandey VN
    J Virol; 2008 Jun; 82(12):5761-73. PubMed ID: 18400844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment.
    Paul D; Hoppe S; Saher G; Krijnse-Locker J; Bartenschlager R
    J Virol; 2013 Oct; 87(19):10612-27. PubMed ID: 23885072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient initiation of HCV RNA replication in cell culture.
    Blight KJ; Kolykhalov AA; Rice CM
    Science; 2000 Dec; 290(5498):1972-4. PubMed ID: 11110665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Ahmed-Belkacem A; Ahnou N; Barbotte L; Wychowski C; Pallier C; Brillet R; Pohl RT; Pawlotsky JM
    Gastroenterology; 2010 Mar; 138(3):1112-22. PubMed ID: 19962982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral therapy: inhibition of Hepatitis C Virus expression by RNA interference directed against the NS5B region of the viral genome.
    Trejo-Avila L; Elizondo-González R; Trujillo-Murillo Kdel C; Zapata-Benavides P; Rodríguez-Padilla C; Rivas-Estilla AM
    Ann Hepatol; 2007; 6(3):174-80. PubMed ID: 17786145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a cell-based high-throughput specificity screen using a hepatitis C virus-bovine viral diarrhea virus dual replicon assay.
    O'Boyle DR; Nower PT; Lemm JA; Valera L; Sun JH; Rigat K; Colonno R; Gao M
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1346-53. PubMed ID: 15793110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ISGylation of Hepatitis C Virus NS5A Protein Promotes Viral RNA Replication via Recruitment of Cyclophilin A.
    Abe T; Minami N; Bawono RG; Matsui C; Deng L; Fukuhara T; Matsuura Y; Shoji I
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32727878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid droplet-binding protein TIP47 regulates hepatitis C Virus RNA replication through interaction with the viral NS5A protein.
    Vogt DA; Camus G; Herker E; Webster BR; Tsou CL; Greene WC; Yen TS; Ott M
    PLoS Pathog; 2013; 9(4):e1003302. PubMed ID: 23593007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new stochastic model for subgenomic hepatitis C virus replication considers drug resistant mutants.
    Ivanisenko NV; Mishchenko EL; Akberdin IR; Demenkov PS; Likhoshvai VA; Kozlov KN; Todorov DI; Gursky VV; Samsonova MG; Samsonov AM; Clausznitzer D; Kaderali L; Kolchanov NA; Ivanisenko VA
    PLoS One; 2014; 9(3):e91502. PubMed ID: 24643004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication.
    Lam AM; Murakami E; Espiritu C; Steuer HM; Niu C; Keilman M; Bao H; Zennou V; Bourne N; Julander JG; Morrey JD; Smee DF; Frick DN; Heck JA; Wang P; Nagarathnam D; Ross BS; Sofia MJ; Otto MJ; Furman PA
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3187-96. PubMed ID: 20516278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus subgenomic replicon requires an active NS3 RNA helicase.
    Lam AM; Frick DN
    J Virol; 2006 Jan; 80(1):404-11. PubMed ID: 16352565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.